Shuttle Pharmaceuticals, LLC

ROCKVILLE, MD 20850

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $1.95MM
First Award Date 09/19/14
Most Recent Award Date 09/19/16

Key Personnel

Last Name Name Awards Contact
PHILLIPS THEODORE L. PHILLIPS 1
RHIM JOHNG RHIM 1
GRINDROD PHD SCOTT GRINDROD 1

3 Awards Won

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/16 - 09/18/17

Patients treated for prostate cancer may experience treatment related late effects that adversely affect quality of life and may prove life-threatening. The objective of this Phase I SBIR application is to determine the technical and commercial feasibility of a biomarker panel predictive of radiation mediated late effects in patients treated for...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/16 - 06/18/17

Prostate cancer health disparities studies have shown that African-American (AA) men are at higher risk for developing prostate cancer, as well as at higher risk of cancer specific death rates as compared to Caucasian American (CA) men. The causes of disparities have been attributed to socioeconomic differences, environmental exposures and biolo...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/19/14 - 08/03/17

The objective of this fast-track SBIR Application is to advance commercialization efforts for IPdR (5-iodo-2pyrimidinone-2'-deoxyribose), a prod rug of the radiosensitizer IUdR (5-iodo-2'-deoxyuridine). In the Phase I SBIR, we will determine the scientific merit, feasibility and potential for commercialization of oral lPdR as a radiation sensiti...